Skip to main content
. 2021 May 27;13:453–464. doi: 10.2147/CEOR.S304868

Table 2.

Cost-Effectiveness Analysis

Traditional Instruments (“AS IS” Scenario) Traditional Instruments + GA (“TO BE” Scenario)
Weighted average cost, considering the therapeutic switch € 233.08 € 230.61
Efficacy (Shima et al, 2014) 71.60% 97.00%
CEV – Cost-Effectiveness Value 325.53 237.74